0 701

Cited 0 times in

Cited 12 times in

Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time

DC Field Value Language
dc.contributor.authorKoo, Tai Yeon-
dc.contributor.authorLee, Ju Han-
dc.contributor.authorMin, Sang-Il-
dc.contributor.authorLee, Yonggu-
dc.contributor.authorKim, Myoung Soo-
dc.contributor.authorHa, Jongwon-
dc.contributor.authorKim, Soon Il-
dc.contributor.authorAhn, Curie-
dc.contributor.authorKim, Yu Seun-
dc.contributor.authorKim, Jayoun-
dc.contributor.authorHuh, Kyu Ha-
dc.contributor.authorYang, Jaeseok-
dc.date.accessioned2021-09-29T01:33:22Z-
dc.date.available2021-09-29T01:33:22Z-
dc.date.created2021-11-23-
dc.date.issued2021-07-
dc.identifier.issn0085-2538-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184426-
dc.description.abstractHLA-incompatible living donor kidney transplantation (LDKT) is one of efforts to increase kidney transplantation opportunity for sensitized patients with kidney failure. However, there are conflicting reports for outcomes of HLA-incompatible kidney transplantation compared to patients who wait for HLA-compatible deceased donor kidney transplantation (DDKT) in the United States and United Kingdom. Waiting for an HLA-compatible DDKT is relatively disadvantageous in Korea, because the average waiting time is more than five years. To study this further, we compared outcomes of HLA-incompatible LDKT with those who wait for HLA-compatible DDKT in Korea. One hundred eighty nine patients underwent HLA-incompatible LDKT after desensitization between 2006 and 2018 in two Korean hospitals (42 with a positive complement-dependent cytotoxicity cross-match, 89 with a positive flow cytometric cross-match, and 58 with a positive donor-specific antibody with negative cross-match). The distribution of matched variables was comparable between the HLA-incompatible LDKT group and the matched control groups (waiting-list-only group; and the waiting-list-or-HLA-compatible-DDKT groups; 930 patients each). The HLA-incompatible LDKT group showed a significantly better patient survival rate compared to the waiting-list-only group and the waiting-list-or-HLA-compatible-DDKT groups. Furthermore, the HLA-incompatible LDKT group showed a significant survival benefit as compared with the matched groups at all strength of donor-specific antibodies. Thus, HLA-incompatible LDKT could have a survival benefit as compared with patients who were waitlisted for HLA-compatible DDKT or received HLA-compatible DDKT in Korea. This suggests that HLA-incompatible LDKT as a good option for sensitized patients with kidney failure in countries with prolonged waiting times for DDKT.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfKidney International-
dc.relation.isPartOfKIDNEY INTERNATIONAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titlePresence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorKoo, Tai Yeon-
dc.contributor.googleauthorLee, Ju Han-
dc.contributor.googleauthorMin, Sang-Il-
dc.contributor.googleauthorLee, Yonggu-
dc.contributor.googleauthorKim, Myoung Soo-
dc.contributor.googleauthorHa, Jongwon-
dc.contributor.googleauthorKim, Soon Il-
dc.contributor.googleauthorAhn, Curie-
dc.contributor.googleauthorKim, Yu Seun-
dc.contributor.googleauthorKim, Jayoun-
dc.contributor.googleauthorHuh, Kyu Ha-
dc.contributor.googleauthorYang, Jaeseok-
dc.identifier.doi10.1016/j.kint.2021.01.027-
dc.relation.journalcodeJ01941-
dc.identifier.eissn1523-1755-
dc.subject.keyworddesensitization-
dc.subject.keyworddonor-specific antibody-
dc.subject.keywordHLA incompatible-
dc.subject.keywordkidney transplantation-
dc.subject.keywordwaiting time-
dc.contributor.alternativeNameKim, Myoung Soo-
dc.contributor.affiliatedAuthorLee, Ju Han-
dc.contributor.affiliatedAuthorKim, Myoung Soo-
dc.contributor.affiliatedAuthorKim, Soon Il-
dc.contributor.affiliatedAuthorKim, Yu Seun-
dc.contributor.affiliatedAuthorHuh, Kyu Ha-
dc.identifier.scopusid2-s2.0-85103968273-
dc.identifier.wosid000667738200027-
dc.citation.volume100-
dc.citation.number1-
dc.citation.startPage206-
dc.citation.endPage214-
dc.identifier.bibliographicCitationKidney International, Vol.100(1) : 206-214, 2021-07-
dc.identifier.rimsid71718-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthordesensitization-
dc.subject.keywordAuthordonor-specific antibody-
dc.subject.keywordAuthorHLA incompatible-
dc.subject.keywordAuthorkidney transplantation-
dc.subject.keywordAuthorwaiting time-
dc.subject.keywordPlusANTIBODY-MEDIATED REJECTION-
dc.subject.keywordPlusCROSS-MATCH-
dc.subject.keywordPlusRENAL-TRANSPLANTATION-
dc.subject.keywordPlusRECIPIENTS-
dc.subject.keywordPlusRITUXIMAB-
dc.subject.keywordPlusDESENSITIZATION-
dc.subject.keywordPlusPREDICTION-
dc.subject.keywordPlusMANAGEMENT-
dc.subject.keywordPlusOUTCOMES-
dc.subject.keywordPlusTHERAPY-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryUrology & Nephrology-
dc.relation.journalResearchAreaUrology & Nephrology-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.